Enjoy complimentary customisation on priority with our Enterprise License!
The renal dialysis market size is estimated to grow by USD 65.79 billion at a CAGR of 8.77% between 2022 and 2027. The increasing prevalence of kidney diseases, including chronic kidney disease (CKD) and end-stage renal disease (ESRD), is leading to a growing demand for kidney care services and treatments. The growing geriatric population is also contributing to the rise in kidney disease cases, as older adults are more prone to developing kidney problems. Additionally, the lack of kidney donors is a key factor driving the demand for alternative treatments such as dialysis and transplantation, which are major components of the market.
It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, View Report Sample
This market report extensively covers market segmentation by end-user (in-center dialysis and home dialysis), type (hemodialysis, peritoneal, and others), and geography (North America, Asia, Europe, and the Rest of World (ROW)).
The market share growth by the in center dialysis segment will be significant during the forecast period. In center dialysis is one of the most common options for patients who require renal dialysis treatment, and it remains a significant segment of the market. It refers to a process in which patients visit a dialysis center or a hospital to have their blood cleaned and treated by a trained medical professional.
Get a glance at the market contribution of various segments View the PDF Sample
The in center dialysis segment was valued at USD 57.33 billion in 2017. Center dialysis services are available worldwide and the demand for this form of treatment continues to grow. As the number of patients with kidney disease increases due to the rapid aging of the population and the increase in lifestyle-related diseases, it is expected that the need for inpatient dialysis will continue to grow. Additionally, advances in technology have made center dialysis procedures more efficient and patient-friendly. This has also increased the demand for inpatient dialysis services for kidney disease patients. The increasing prevalence of chronic kidney disease also contributes to the growth of the institutional dialysis segment during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. In 2022, North America dominated the market. In North America, the United States has the highest revenue, with the main factors dominating other countries in the region being the growing elderly population and increasing prevalence of ESRD. Some other factors that led to the US dominating the North American market in 2022 are high medical awareness, a developed healthcare infrastructure, and government aggressiveness to promote FDA-approved machines. Also, the large market share of the US can be attributed to the rising cases of kidney failures, expensive transplantation procedures in the country, and the availability of advanced healthcare infrastructure, which ensures the continuous supply of dialysis devices and systems to patients undergoing renal dialysis. Such factors will increase the market growth in this region during the forecast period.
The market is driven by the increasing incidence of renal diseases, particularly ESRD (End-Stage Renal Disease), which necessitates dialysis as a life-sustaining treatment. Technological advancements have led to the development of portable dialysis equipment, improving the quality of life for patients. Public healthcare spending and awareness campaigns are also contributing factors. Conditions such as diabetes and hypertension are leading causes of kidney damage, highlighting the importance of managing these conditions. Kidney transplantation remains the preferred option, but with limited availability, it plays a crucial role in waste product removal and managing associated risks like high blood pressure, heart disease, and stroke, reducing the likelihood of early death in patients. According to the CDC (Centers for Disease Control and Prevention), a significant number of Americans suffer from Chronic Kidney Disease (CKD), further driving the demand for these services and equipment among medical professionals. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Lack of kidney donors is the key factor driving the growth of the market. Kidney transplantation has been accepted globally as a treatment option for ESRD. Renal transplantation is well established in countries like the US, India, and South Africa. According to the United States Renal Data System (USRDS), approximately 140,000 people are living with transplanted kidneys. Although the number of kidney transplantations is growing every year, there is an increasing waiting list.
Furthermore, there is little demand for kidney transplantation in low- and middle-income countries, as most patients cannot afford it. There are certain risks before and after kidney transplantation, including infection, bleeding, and damage to surrounding organs. Public healthcare spending and awareness campaigns play a crucial role in addressing these risks, especially considering the high prevalence of risk factors such as diabetes and hypertension among Americans with chronic kidney disease (CKD). Medical professionals often consider treatments like peritoneal dialysis to manage the incidence of renal diseases before transplantation. Transplant failure and lack of suitable kidney donors can lead to increased renal failure in patients undergoing dialysis treatment, which increases the demand for renal dialysis. Hence, such factors are expected to drive the growth of the market during the forecast period.
Initiatives to increase public awareness, physician education, and clinical training are the primary trends in the market. Many public and non-profit private organizations are undertaking initiatives to raise awareness and improve care and treatment for people diagnosed with kidney disease. The National Kidney Foundation (NKF) is the largest, most comprehensive, and longest-established organization dedicated to raising awareness, prevention, and treatment of kidney disease in the United States. The organization also conducts health-related activities such as free health checkups, online kidney tests, and expert consultations to raise awareness about kidney health and risk factors for diseases that affect the organ.
Moreover, the leading companies in the market, such as Boston Scientific Corporation and Cook, also offer clinical education and training programs for physicians to upgrade their skills in using their latest product innovations. This helps companies increase their product sales and strengthen their position in the market. Such initiatives and training programs are driving the growth of the global market during the forecast period.
High treatment costs are a major challenge to the growth of the market. The high cost of dialysis treatment is hindering market growth, especially in low- and middle-income countries where a large portion of the population is unfamiliar with dialysis treatment. State guidelines for ESRD coverage and reimbursement vary by country. Dialysis treatment consumes a lot of resources because dialysis equipment and materials are expensive. Costs incurred during renal dialysis treatment for renal failure include direct medical costs, direct nonmedical costs, intangible costs, and indirect costs.
However, intangible or indirect costs are often neglected, as they are difficult to quantify and are rarely assessed in dialysis economic evaluations. Hemodialysis is more expensive when compared with peritoneal dialysis in high-income countries. The increasing cost of treatment for renal diseases restrains the growth of the market due to the lower adoption of high-cost treatment, especially for individuals in lower-middle-income countries where most of the world's population resides. Hence, such factors are expected to hinder the growth of the global renal dialysis market during the forecast period.
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Asahi Kasei Corp.: The company offers renal extracorporeal blood purification technique which is used for patients with chronic kidney disease who are not able to receive kidney transplant.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
The market is experiencing significant growth due to factors such as an aging population, increasing healthcare costs, and a rise in discretionary income. Technological advancements, such as the development of innovative technologies and external blood-cleansing devices, are driving market expansion. The market also benefits from government initiatives like the Chronic Kidney Disease (CKD) Initiative and the Pradhan Mantri National Dialysis Programme (PMNDP). With the prevalence of renal disorders increasing globally, the demand for dialysis equipment such as dialyzers, dialysis concentrates, and dialysis catheters is expected to rise, especially in industrialized and developing countries.
The kidney dialysis industry plays a crucial role in treating individuals with chronic renal disease, including those with end-stage renal diseases (ESRD). Technological advancements have led to the development of sophisticated equipment such as the 4008A dialysis machine, which is used in dialysis procedures. Dialysis is also being explored in the treatment of animal renal failure, with institutions like the Cornell University Hospital for Animals utilizing extracorporeal blood purification (EBP) devices. The market is driven by the increasing prevalence of obesity and diabetes mellitus, contributing to a rise in mortality rates related to renal disorders. Additionally, initiatives like the CKD Surveillance System and Healthy People objectives aim to address the challenges posed by renal diseases, especially among minority populations such as non-Hispanic Black adults, non-Hispanic White adults, non-Hispanic Asian adults, and adult Hispanics.
Market Scope |
|
Report Coverage |
Details |
Page number |
167 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.77% |
Market growth 2023-2027 |
USD 65.79 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
7.5 |
Regional analysis |
North America, Asia, Europe, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Baxter International Inc., AngioDynamics Inc., Asahi Kasei Corp., B. Braun Melsungen AG, Becton Dickinson and Co., DaVita Inc., Dialysis Clinic Inc., Diaverum AB, Fresenius Medical Care AG and Co. KGaA, JMS Co. Ltd., Medtronic Plc, Merck and Co. Inc., Nikkiso Co. Ltd., Nipro Corp., Nxstage Medical Inc., Physidia, Satellite Healthcare Inc., STERIS Plc, Toray Industries Inc., and US Renal Care |
Market dynamics |
Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.